Pyrls’ Post

The FDA has approved the first generic once-daily GLP-1 injection, liraglutide, for type 2 diabetes. This milestone aims to make diabetes treatment more accessible and affordable. Liraglutide helps regulate blood sugar and can aid in weight loss. This approval is a significant step towards better diabetes management. #FDA #Diabetes #Healthcare #GLP1 #Liraglutide #MedicalNews You can read more about it here: https://lnkd.in/exTzqYNG

GLP-1 medications like Ozempic have been a game changer for people with type 2 diabetes. But why are these miracle drugs off-limits to people with type 1 diabetes? Unfortunately, these medications haven’t yet been approved by the FDA for use in type 1 diabetes because there haven’t been enough studies to demonstrate that the benefits outweigh the risks. But several studies are underway to test adjunctive therapies in type 1 diabetes. Here’s a look into adjunctive therapies like GLP-1s, their benefits and risks, and the challenges in accessing them >> bit.ly/3XAN9sK #myAMCR #HeadlandsResearchAMCR #Type1Diabetes #DiabetesManagement #DiabetesStudies #Type1DiabetesTreatment

I have respect for ISMP. Yes...counterfeits exist and YES there are those that will certainly try to not follow the rules. However, ISMP is stating here to NOT use compounded versions of Tirzepetide of course siting the 2012 NECC issue..THE worst possible case scenario. It also INCORRECTLY states that the drug is ONLY available through Eli Lilly. YES the official drug as marketed is only available through them. However, an Active Pharmaceutical Ingredient can be used through a licensed supplier for the powder to be compounded. It's also worth noting..compounding is being done every day. Go tell a Urologist that it's no longer safe to order TRIMIX for his ED patients. Perhaps compounded Opthalmic meds should no longer be done. The argument NEEDS to stand across the board...if your argument is that compounding can lead to these health risks...then the risk exist for all and not 1 drug. That means...ALL COMPOUNDED IV ANTIBIOTICS...ALL IV INOTROPES..ALL COMPOUNDS FOR PETS..EVERYTHING. Yes the issue is real for Tirzepatide, but let's focus on WHY Eli Lilly is so focused on this...MONEY..just as much and the counterfeiters. In my career I have never seen a manufacturer test a compounded drug to prove a point. Plus, if we are comparing a manufacturer ability to produce vs a compound, the 2 will NEVER be equal.

🌟 Tria Triumph: GLP-1’s are Not for Everyone! 🌟 A patient with diabetes and a history of a heart attack initially faced GI discomfort from metformin IR. After a change in medication to Ozempic, their GI symptoms worsened dramatically. The patient described the issues as “wicked” with severe gas, nausea, and diarrhea. Our Tria Health pharmacist stepped in, thoroughly investigating the timeline of symptoms and medication changes. By pinpointing Ozempic as the likely cause, the pharmacist recommended discontinuing it and returning to metformin, this time in the extended-release (ER) formulation. Today, the patient’s HgbA1C and blood glucose levels are at goal, thanks to careful medication management and personalized care. This case highlights the power of attentive pharmaceutical care in achieving optimal health outcomes. #GLP1 #PersonalizedCare #MedicationManagement

Understanding Headaches: Migraines are intense, often with nausea and light sensitivity, lasting several days. Tension headaches, however, present milder symptoms and respond well to OTC medications. Seeking effective treatment? Consult your pharmacist for personalized advice. #ProfessionalHealth #WellnessAtWork #WellerPharmacy #CommunityPharmacy

FDA Approved First Generic of OD GLP-1 Injection Lower blood sugar in patients with Type 2 Diabetes. 🔴Referencing as; 🔸Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1). 🔴Type 2 diabetes is a chronic condition that occurs when the body does not use insulin well. 🔴The prescribing information for the generic liraglutide injection approved includes a Boxed Warning to advise health care professionals and patients about the increased risk of thyroid C-cell tumors. Source: FDA Link: https://lnkd.in/dv8AFSRV #Type2Diabetes #DiabetesTreatment #SugarLevelManagement PharmixVision

Today, the American Diabetes Association® issued a statement against using non-FDA approved compounded GLP-1 and dual GIP/GLP-1 RA products. Safety, quality, and effectiveness may be at risk. Read more at bit.ly/4eVY6tN.

In recent years, GLP-1 receptor agonists have become vital tools for managing type 2 diabetes and obesity. Their growing popularity, however, has led to increased demand, product shortages, and the rise of compounded alternatives. While compounded GLP-1 formulations may appear to offer affordable solutions, they come with serious risks, including concerns around dosing accuracy, potential counterfeit products, and lack of FDA regulation. As highlighted in the American Diabetes Association's recent statement, compounded versions bypass critical safety measures—posing dangers for patients who are not closely monitored by healthcare professionals. In a recent blog, we explore the importance of close monitoring when patients use GLP-1 medications. For insulin pump users, the stakes are even higher, as any variability in medication safety or efficacy can have significant consequences for blood glucose management. Ultimately, ensuring access to regulated, FDA-approved medications is essential for optimal outcomes in diabetes care. 🔗 Find more in our blog here: https://lnkd.in/gCxANB_e

We welcome the ADA’s guidance against unapproved compounded medicines, which rightly points out the “uncertainty about their content, safety, quality, and effectiveness.” No patient should be exposed to unapproved knockoff drugs with heightened risks, particularly when safe and effective FDA-approved medicines are available. Mass-produced unapproved drugs may expose patients to potentially life-threatening risks. Patient safety remains Lilly's top concern, but our efforts alone are not enough. We appreciate the ADA’s continued commitment to patient safety.

What’s the difference between a tension headache and a migraine? Migraines are debilitating headaches that often result in nausea, vomiting, and extreme sensitivity to light and can last for days at a time. Tension headaches, on the other hand, are much milder. They often cause pain on both sides of the head and pressure behind the eyes, in the neck or jaw, or on top of the head, and can be treated with over-the-counter medications. To find the right products to ease your headaches, talk to your pharmacist today. https://lnkd.in/gR2E3BZF #PharmaChoice #Pharmacy #PharmaChoiceCanada #PharmacistsCare #CommunityPharmacy #YourPharmacy #PCH #PCC #LoveMyPharmacy #Pharmacy24